Studies of obinutuzumab, a type II anti-CD20 antibody, have shown efficacy in the treatment of hematologic cancers and autoimmune diseases. An evaluation of the efficacy and safety of obinutuzumab in ...
It's hard to conceive of a nastier workplace than Mouthwashing's spaceship - that delirious, foam-clogged labyrinth of cracked sunsets and fire-freshness - but developers Wrong Organ are certainly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results